Henrique Bittencourt

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner et al. · New England Journal of Medicine · 2018 · 5.4K citations · Full text

Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia

Elena J. Orlando, Xia Han, Catherine Tribouley et al. · Nature Medicine · 2018 · 542 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Malignant Blood Disorder +11

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

Theodore W. Laetsch, Shannon L. Maude, Susana Rives et al. · Journal of Clinical Oncology · 2022 · 314 citations · Full text

Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis

Imke H. Bartelink, Arief Lalmohamed, Elisabeth M L van Reij et al. · The Lancet Haematology · 2016 · 279 citations · Full text

Haemopoietic Cell Transplantation, Busulfan Exposure, Transplantation +10

Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

Joanne Kurtzberg, Susan E. Prockop, Pierre Teira et al. · Biology of Blood and Marrow Transplantation · 2013 · 242 citations · Full text